Showing results (171-180 of 629) with videos related to

Sort By:
Pageof 63
European Heart Journal. Cardiovascular Pharmacotherapy|June 11, 2021
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery diseaseFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
JACC. Cardiovascular Interventions|November 1, 2022
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 StudyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 10, 2018
Cardiorenal Safety of OTC AnalgesicsWilliam B White, Robert A Kloner, Dominick J Angiolillo, et al.
Idcases|June 14, 2019
Endocarditis caused by Stenotrophomonas maltophilia-A rare presentation of an emerging opportunistic pathogenWilliam Kogler, Nancy Davison, Aaron Richardson, et al.
Expert Review of Cardiovascular Therapy|December 17, 2021
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular eventsDario Calderone, Salvatore Ingala, Maria Sara Mauro, et al.
Frontiers in Cardiovascular Medicine|March 3, 2022
The Role of Antiplatelet Therapy in Patients With MINOCALuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
The American Journal of Cardiology|January 27, 2009
Advances in antiplatelet therapy: agents in clinical developmentDominick J Angiolillo, Deepak L Bhatt, Paul A Gurbel, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularizationDavid E Kandzari, Dominick J Angiolillo, Matthew J Price, et al.
Journal of the American College of Cardiology|December 8, 2018
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline ComparisonDavide Capodanno, Fernando Alfonso, Glenn N Levine, et al.
Pageof 63